< Back to previous page
Researcher
Simon Planken
- Keywords:Medicine
- Disciplines:Other basic sciences not elsewhere classified
Affiliations
- Hematology (Department)
Member
From1 Oct 2023 → Today - Faculty of Medicine and Pharmacy (Faculty)
Member
From28 Aug 2015 → Today - Internal medicine (Department)
Member
From30 Jan 2023 → 30 Sep 2023 - Intensive Care (Department)
Member
From1 Oct 2022 → 29 Jan 2023 - Internal medicine (Department)
Member
From1 Jul 2020 → 30 Sep 2021 - Hematology (Department)
Member
From3 Feb 2020 → 30 Jun 2020 - Internal medicine (Department)
Member
From1 Oct 2019 → 2 Feb 2020 - Faculty of Medicine and Pharmacy (Faculty)
Member
From13 Aug 2018 → 27 Apr 2023
Publications
1 - 2 of 2
- Illustrative cases for monitoring by quantitative analysis of BRAF/NRAS ctDNA mutations in liquid biopsies of metastatic melanoma patients who gained clinical benefits from anti-PD1 antibody therapy(2018)
Authors: Teofila Seremet, Simon Planken, Max Schreuer, Yanina Jansen, Mélanie Delaunoy, Hakim El Housni, Danielle Lienard, Véronique Del Marmol, Pierre Heimann, Bart Neyns
Pages: 65-70 - Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF(V600)-mutant melanoma(2017)
Authors: Max Schreuer, Yanina Jansen, Simon Planken, Ines Chevolet, Teofila Seremet, Vibeke Krüse, Bart Neyns
Pages: 464-472